Učitavanje...
Radiofrequency combined with immunomodulation for hepatocellular carcinoma: State of the art and innovations
Hepatocellular carcinoma (HCC) is the most common primary liver tumor and has been considered a very immunogenic tumor. The treatment with radiofrequency ablation (RFA) has been established as the standard ablative therapy for early HCC, and is currently recognized as the main ablative tool for HCC...
Spremljeno u:
| Izdano u: | World J Gastroenterol |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Baishideng Publishing Group Inc
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7267689/ https://ncbi.nlm.nih.gov/pubmed/32536773 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v26.i17.2040 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|